Why and how to study the fate of cancer survivors: Observations from the clinic and the research laboratory

European Journal of Cancer

Volumn 39, Issue 15, 2003, Pages 2136-2141

  Ganz, P A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer survivors; Childhood leukaemia; Late effects; Registries

Indexed keywords

ANTHRACYCLINE;

CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CARDIOTOXICITY; CHILDHOOD LEUKEMIA; DATA BASE; HEALTH STATUS; HEALTH SURVEY; HUMAN; LABORATORY; LONG TERM CARE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0142091604     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00489-1     Document Type: Article

References (52)

1. Aareleid T., Sant M., Hedelin G. Improved survival for patients with testicular cancer in Europe since 1978. Eur J Cancer. 34:1998;2236-2240.
2. Wingo P.A., Ries L.A., Rosenberg H.M., Miller D.S., Edwards B.K. Cancer incidence and mortality, 1973-1995. a report card for the US Cancer. 82:1998;1197-1207.
3. Brenner H., Soderman B., Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates. empirical evaluation among 370 000 cancer patients in Finland Int. J. Epidemiol. 31:2002;456-462.
4. Sant M., Capocaccia R., Coleman M.P.et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer. 37:2001;1659-1667.
5. Mullan F. Seasons of survival. reflections of a physician with cancer N. Engl. J. Med. 313:1985;270-273.
6. Gatta G., Capocaccia R., Coleman M.P., Ries L.A., Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 95:2002;1767-1772.
7. Meadows A.T. Second tumours. Eur J Cancer. 37:2001;2074-2079.
8. Hawkins M.M. Commentary. Eur J Cancer. 37:2001;2079-2081.
9. National Cancer Institute, Office of Cancer Survivorship. Estimated US Cancer Prevalence Counts: Who Are Cancer Survivors in the US? Website, http://dccps.nci.nih.gov/ocs/prevalence/prevalence.html#survivor, 2003.
10. Editorial. Eur J Cancer 1989, 34, 2137-2138.
11. Gatta G., Capocaccia R., Coleman M.P.et al. Toward a comparison of survival in American and European cancer patients. Cancer. 89:2000;893-900.
12. Steinherz L.J., Steinherz P.G., Tan C. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy. a series of 15 patients Med. Pediatr. Oncol. 24:1995;352-361.
13. Kremer L.C.M., van Dalen E.C., Offringa M., Ottenkamp J., Voute P.A. Anthracycline-induced clinical heart failure in a cohort of 607 children. long-term follow-up study J. Clin. Oncol. 19:2001;191-196.
14. Ganz P.A. Late effects of cancer and its treatment. Semin. Oncol. Nurs. 17:2001;241-248.
15. Lippman M.E., Hayes D.F. Adjuvant therapy for all patients with breast cancer? J. Natl. Cancer Inst. 93:2001;80-82.
16. Ganz P.A., Desmond K.A., Leedham B., Rowland J.H., Meyerowitz B.E., Belin T.R. Quality of life in long-term, disease-free survivors of breast cancer. a follow-up study J. Natl. Cancer Inst. 94:2002;39-49.
17. Phillips K.A., Bernhard J. Adjuvant breast cancer treatment and cognitive function. current knowledge and research directions J. Natl. Cancer Inst. 95:2003;190-197.
18. Madalinska J.B., Essink-Bot M.L., de Koning H.J.et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J. Clin. Oncol. 19:2001;1619-1628.
19. Krisch E.B., Koprowski C.D. Deciding on radiation therapy for prostate cancer. the physician's perspective Semin. Urol. Oncol. 18:2000;214-225.
20. Ganz P.A., Litwin M.S. Prostate cancer. the price of early detection J. Clin. Oncol. 19:2001;1587-1588.
21. Litwin M.S. Quality of life following definitive therapy for localized prostate cancer. potential impact of multiple therapies Curr. Opin. Urol. 13:2003;153-156.
22. Yancik R., Ganz P.A., Varricchio C.G., Conley B. Perspectives on comorbidity and cancer in older patients. approaches to expand the knowledge base J. Clin. Oncol. 19:2001;1147-1151.
23. Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Edwards B.K., Yates J.W. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 285:2001;885-892.
24. Yancik R. Epidemiology of cancer in the elderly. Current status and projections for the future. Rays. 22:1997;3-9.
25. Edwards B.K., Howe H.L., Ries L.A.et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 94:2002;2766-2792.
26. Hewitt M., Rowland J.H., Yancik R. Cancer survivors in the united states. age, health, and disability J. Gerontol. A Biol. Sci. Med. Sci. 58:2003;M82-M91.
27. Yancik R., Ries L.A. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol. Oncol. Clin. North Am. 14:2000;17-23.
28. Centers for disease control and prevention: trends in aging - United States and Worldwide. MMWR 2003, 52, 101-106.
29. Coebergh J.W. Epidemiology in Europe. Eur. J. Cancer. 37(Suppl. 7):2001;S217-S227.
30. Potosky A.L., Harlan L.C., Stanford J.L.et al. Prostate cancer practice patterns and quality of life. the Prostate Cancer Outcomes Study J. Natl. Cancer Inst. 91:1999;1719-1724.
31. Stanford J.L., Feng Z., Hamilton A.S.et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. the Prostate Cancer Outcomes Study JAMA. 283:2000;354-360.
32. Hamilton A.S., Stanford J.L., Gilliland F.D.et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer. results from the Prostate Cancer Outcomes Study J. Clin. Oncol. 19:2001;2517-2526.
33. Mertens A.C., Yasui Y., Neglia J.P.et al. Late mortality experience in five-year survivors of childhood and adolescent cancer. The Childhood Cancer Survivor Study J. Clin. Oncol. 19:2001;3163-3172.
34. Ganz P.A., Rowland J.H., Desmond K., Meyerowitz B.E., Wyatt G.E. Life after breast cancer. understanding women's health-related quality of life and sexual functioning J. Clin. Oncol. 16:1998;501-514.
35. Litwin M.S., Hays R.D., Fink A.et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
36. Pakilit A.T., Kahn B.A., Petersen L., Abraham L.S., Greendale G.A., Ganz P.A. Making effective use of tumor registries for cancer survivorship research. Cancer. 92:2001;1305-1314.
37. Vassilopoulou-Sellin R., Brosnan P., Delpassand A., Zietz H., Klein M.J., Jaffe N. Osteopenia in young adult survivors of childhood cancer. Med. Pediatr. Oncol. 32:1999;272-278.
38. Hewitt M., Breen N., Devesa S. Cancer prevalence and survivorship issues. analyses of the 1992 National Health Interview Survey J. Natl. Cancer Inst. 91:1999;1480-1486.
39. King V., Constine L.S., Clark D.et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 36:1996;881-889.
40. Knobel H., Loge J.H., Lund M.B., Forfang K., Nome O., Kaasa S. Late medical complications and fatigue in Hodgkin's disease survivors. J. Clin. Oncol. 19:2001;3226-3233.
41. Fossa S.D., Aass N., Winderen M., Bormer O.P., Olsen D.R. Long-term renal function after treatment for malignant germ-cell tumours. Ann. Oncol. 13:2002;222-228, 2002.
42. Travis L.B., Curtis R.E., Glimelius B.et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J. Natl. Cancer Inst. 85:1993;1932-1937.
43. Travis L.B., Curtis R.E., Storm H.et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J. Natl. Cancer Inst. 89:1997;1429-1439.
44. Metayer C., Lynch C.F., Clarke E.A.et al. Second cancers among long-term survivors of hodgkin's disease diagnosed in childhood and adolescence. J. Clin. Oncol. 18:2000;2435-2443.
45. Socie G., Curtis R.E., Deeg H.J.et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J. Clin. Oncol. 18:2000;348.
46. Dores G.M., Metayer C., Curtis R.E.et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease. a population-based evaluation over 25 years J. Clin. Oncol. 20:2002;3484-3494.
47. Gilbert E.S., Stovall M., Gospodarowicz M.et al. Lung cancer after treatment for Hodgkin's disease. focus on radiation effects Radiat. Res. 159:2003;161-173.
48. Bhatia S., Robison L.L., Oberlin O.et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 334:1996;745-751.
49. Bhatia S., Meadows A.T., Robison L.L. Second cancers after pediatric Hodgkin's disease. J. Clin. Oncol. 16:1998;2570-2572.
50. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N. Engl. J. Med. 347:2002;567-575.
51. Potosky A.L., Riley G.F., Lubitz J.D., Mentnech R.M., Kessler L.G. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med. Care. 31:1993;732-748.
52. Potosky A.L., Warren J.L., Riedel E.R., Klabunde C.N., Earle C.C., Begg C.B. Measuring complications of cancer treatment using the SEER-Medicare data. Med. Care. 40:2002;IV-8.